Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We have recently reported high levels of fluoroquinolone resistance in a single region of Kenya. In this article, we report high prevalence of fluoroquinolone resistance (53.2%) in Neisseria gonorrhoeae isolates from 4 clinics in 3 additional regions of Kenya. These findings highlight the need to change first-line treatment in these settings and the need to evaluate empirical management guidelines for treatment of gonococcal infection in Kenya.

Original publication

DOI

10.1097/OLQ.0b013e318248a85f

Type

Journal article

Journal

Sex Transm Dis

Publication Date

05/2012

Volume

39

Pages

332 - 334

Keywords

Adult, Drug Resistance, Bacterial, Female, Fluoroquinolones, Gonorrhea, Humans, Kenya, Male, Mass Screening, Microbial Sensitivity Tests, Neisseria gonorrhoeae, Prevalence, Sentinel Surveillance